Exposure-Response Analysis of Dostarlimab in Combination with Platinum-Containing Chemotherapy in Primary Advanced or Recurrent Endometrial Cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial

Kuchimanchi, Mita; Koliadi, Anthoula; Pothuri, Bhavana; Alskär, Oskar; Krivak, Tom; Pishchyk, Mikalai; Hanze, Eva; Zajic, Stefan; Segev, Yakir; Backes, Floor J.; Gennigens, Christine; Bouberhan, Sara; Buscema, Joseph; Melhem, Murad; Shahin, Mark S.

Poster (Scientific congresses and symposiums)

Kuchimanchi, Mita; Koliadi, Anthoula; Pothuri, Bhavana et al.

2023 • American Conference on Pharmacometrics (ACoP)

Peer reviewed

Permalink
https://hdl.handle.net/2268/310368

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Dost002580_ACoP2023_RUBY ER_Draft DF_20Oct23[17] Copy.pdf

Author postprint (2.93 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Pharmacy, pharmacology & toxicology
Oncology

Author, co-author :

Kuchimanchi, Mita

Koliadi, Anthoula

Pothuri, Bhavana

Alskär, Oskar

Krivak, Tom

Pishchyk, Mikalai

Hanze, Eva

Zajic, Stefan

Segev, Yakir

Backes, Floor J.

More authors (5 more)

Language :

English

Title :

Exposure-Response Analysis of Dostarlimab in Combination with Platinum-Containing Chemotherapy in Primary Advanced or Recurrent Endometrial Cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial

Publication date :

2023

Event name :

American Conference on Pharmacometrics (ACoP)

Event place :

Maryland, United States

Event date :

November 5–8, 2023

Audience :

International

Peer reviewed :

Peer reviewed

Available on ORBi :

since 27 December 2023

Statistics

Number of views

9 (5 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics